HomeHealthcare & Life SciencesPharmaceuticals Myasthenia Gravis Treatment Market

Brazil Myasthenia Gravis Treatment Market Size & Outlook, 2025-2033


Brazil Myasthenia Gravis Treatment Market Insights

  • According to Reed Intelligence analysis, the Brazil Myasthenia Gravis Treatment Market size was USD 64.22 Million in 2024 and is projected to reach USD 151.62 Million by 2033.
  • The Brazil market is projected to grow at a CAGR of 10.08% between 2026 and 2033.
  • By segment, Ocular MG  emerged as the largest By Type in terms of market size in 2024.
  • Congenital MG  is anticipated to remain the most attractive By Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • In 2024, Brazil accounted for 3.04% of the global Myasthenia Gravis Treatment Market size.
  • By 2033, United States is expected to lead the global Myasthenia Gravis Treatment Market in terms of market size.
  • Within LATAM, Brazil is projected to dominate the regional Myasthenia Gravis Treatment Market size by 2033.
  • Chile is identified as the fastest-growing market in LATAM, anticipated to reach USD 28.08 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 64.22 Million
Market Size In 2033 USD 151.62 Million
Largest segment Ocular MG 
Units Revenue in USD Million
CAGR 10.08% (2025-2033)
Segmnetation Covered
By Type
  1. Ocular MG 
  2. Congenital MG 
  3. Transient Neonatal MG
By Treatment
  1. Medication 
  2. Surgery 
  3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
  4. Plasmapheresis and Intravenous Immunoglobulin 
  5. Others
By End-User
  1. Hospitals 
  2. Clinics 
  3. Academic Research Institutes 
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports